KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 116 filers reported holding KURA ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,425,000 | +483.1% | 500,000 | +178.2% | 2.19% | +1069.5% |
| Q1 2020 | $1,788,000 | -84.8% | 179,700 | -79.0% | 0.19% | -81.7% |
| Q4 2019 | $11,739,000 | -74.9% | 853,777 | -72.3% | 1.02% | -76.2% |
| Q3 2019 | $46,815,000 | -99.9% | 3,086,053 | +1.3% | 4.30% | -35.5% |
| Q2 2019 | $60,011,000,000 | +136655.4% | 3,047,800 | +15.2% | 6.66% | +53.4% |
| Q1 2019 | $43,882,000 | +12.9% | 2,645,100 | -4.5% | 4.34% | -11.6% |
| Q4 2018 | $38,884,000 | +4.9% | 2,769,527 | +30.7% | 4.92% | -15.0% |
| Q3 2018 | $37,084,000 | -22.4% | 2,119,106 | -19.3% | 5.78% | -12.8% |
| Q2 2018 | $47,813,000 | -99.9% | 2,627,110 | +10.3% | 6.63% | -0.0% |
| Q1 2018 | $44,641,000,000 | +132689.0% | 2,380,846 | +8.4% | 6.63% | +15.6% |
| Q4 2017 | $33,618,000 | +28.4% | 2,197,283 | +25.5% | 5.74% | +12.6% |
| Q3 2017 | $26,176,000 | – | 1,750,887 | – | 5.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |